Mainz Biomed BV
NASDAQ:MYNZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mainz Biomed BV
NASDAQ:MYNZ
|
DE |
|
Foris AG
XETRA:FRS
|
DE |
|
Torii Pharmaceutical Co Ltd
TSE:4551
|
JP |
|
Greatwalle Inc
HKEX:8315
|
HK |
|
Riverside Resources Inc
XTSX:RRI
|
CA |
|
X
|
Xinjiang Qingsong Building Materials and Chemicals Group Co Ltd
SSE:600425
|
CN |
|
Telia Company AB
STO:TELIA
|
SE |
|
Dafeng TV Ltd
TWSE:6184
|
TW |
Mainz Biomed BV
Mainz Biomed BV operates as a biotechnology company. The company is headquartered in Mainz, Hessen. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed BV operates as a biotechnology company. The company is headquartered in Mainz, Hessen. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
